SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001193125-23-250784
Filing Date
2023-10-04
Accepted
2023-10-04 16:55:05
Documents
9
Effectiveness Date
2023-10-04

Document Format Files

Seq Description Document Type Size
1 S-8 d539790ds8.htm S-8 63620
2 EX-5.1 d539790dex51.htm EX-5.1 9972
3 EX-23.1 d539790dex231.htm EX-23.1 3628
4 EX-23.2 d539790dex232.htm EX-23.2 1461
5 EX-99.2 d539790dex992.htm EX-99.2 26742
6 EX-FILING FEES d539790dexfilingfees.htm EX-FILING FEES 20294
7 GRAPHIC g539790g0915142142504.jpg GRAPHIC 2257
8 GRAPHIC g539790g0915142142665.jpg GRAPHIC 2221
9 GRAPHIC g539790g0921105024041.jpg GRAPHIC 2242
  Complete submission text file 0001193125-23-250784.txt   136595
Mailing Address 300 TECHNOLOGY SQUARE 8TH FLOOR CAMBRIDGE MA 02139
Business Address 300 TECHNOLOGY SQUARE 8TH FLOOR CAMBRIDGE MA 02139 857-201-2700
Dianthus Therapeutics, Inc. /DE/ (Filer) CIK: 0001690585 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-274865 | Film No.: 231308678
SIC: 2834 Pharmaceutical Preparations